178 related articles for article (PubMed ID: 16906373)
1. Significant elevation of IgG anti-WRN (RecQ3 RNA/DNA helicase) antibody in systemic sclerosis.
Goto M; Okawa-Takatsuji M; Aotsuka S; Nakai H; Shimizu M; Goto H; Shimamoto A; Furuichi Y
Mod Rheumatol; 2006; 16(4):229-34. PubMed ID: 16906373
[TBL] [Abstract][Full Text] [Related]
2. Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis.
Hayakawa I; Hasegawa M; Takehara K; Sato S
Arch Dermatol Res; 2005 Oct; 297(4):180-3. PubMed ID: 16180014
[TBL] [Abstract][Full Text] [Related]
3. Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis.
Hu PQ; Fertig N; Medsger TA; Wright TM
Arthritis Rheum; 2003 May; 48(5):1363-73. PubMed ID: 12746909
[TBL] [Abstract][Full Text] [Related]
4. Anti-agalactosyl IgG antibodies in sera from patients with systemic sclerosis.
Nishijima C; Sato S; Takehara K
J Rheumatol; 2001 Aug; 28(8):1847-51. PubMed ID: 11508588
[TBL] [Abstract][Full Text] [Related]
5. Elevation of IgG levels is a serological indicator for pulmonary fibrosis in systemic sclerosis with anti-topoisomerase I antibodies and those with anticentromere antibody.
Komura K; Yanaba K; Ogawa F; Shimizu K; Takehara K; Sato S
Clin Exp Dermatol; 2008 May; 33(3):329-32. PubMed ID: 18312458
[TBL] [Abstract][Full Text] [Related]
6. Autoantibody against peroxiredoxin I, an antioxidant enzyme, in patients with systemic sclerosis: possible association with oxidative stress.
Iwata Y; Ogawa F; Komura K; Muroi E; Hara T; Shimizu K; Hasegawa M; Fujimoto M; Tomita Y; Sato S
Rheumatology (Oxford); 2007 May; 46(5):790-5. PubMed ID: 17309887
[TBL] [Abstract][Full Text] [Related]
7. Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis.
Nishijima C; Hayakawa I; Matsushita T; Komura K; Hasegawa M; Takehara K; Sato S
Clin Exp Immunol; 2004 Nov; 138(2):357-63. PubMed ID: 15498049
[TBL] [Abstract][Full Text] [Related]
8. Werner protein stimulates topoisomerase I DNA relaxation activity.
Laine JP; Opresko PL; Indig FE; Harrigan JA; von Kobbe C; Bohr VA
Cancer Res; 2003 Nov; 63(21):7136-46. PubMed ID: 14612507
[TBL] [Abstract][Full Text] [Related]
9. IgG reactivity with a 100-kDa tissue and endothelial cell antigen identified as topoisomerase 1 distinguishes between limited and diffuse systemic sclerosis patients.
García de la Peña-Lefebvre P; Chanseaud Y; Tamby MC; Reinbolt J; Batteux F; Allanore Y; Kahan A; Meyer O; Benveniste O; Boyer O; Guillevin L; Boissier MC; Mouthon L
Clin Immunol; 2004 Jun; 111(3):241-51. PubMed ID: 15183145
[TBL] [Abstract][Full Text] [Related]
10. Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations.
Kodera M; Hayakawa I; Komura K; Yanaba K; Hasegawa M; Takehara K; Sato S
J Rheumatol; 2005 Apr; 32(4):629-36. PubMed ID: 15801017
[TBL] [Abstract][Full Text] [Related]
11. WRN protein as a novel erythroblast immunohistochemical marker with applications for the diagnosis of Werner syndrome.
Sadahira Y; Sugihara T; Fujiwara H; Nishimura H; Suetsugu Y; Takeshita M; Okamura S; Goto M
Virchows Arch; 2015 Mar; 466(3):343-50. PubMed ID: 25503078
[TBL] [Abstract][Full Text] [Related]
12. Werner syndrome and mutations of the WRN and LMNA genes in France.
Uhrhammer NA; Lafarge L; Dos Santos L; Domaszewska A; Lange M; Yang Y; Aractingi S; Bessis D; Bignon YJ
Hum Mutat; 2006 Jul; 27(7):718-9. PubMed ID: 16786514
[TBL] [Abstract][Full Text] [Related]
13. Anti-p53 autoantibody in systemic sclerosis: association with limited cutaneous systemic sclerosis.
Hara T; Ogawa F; Muroi E; Komura K; Takenaka M; Hasegawa M; Fujimoto M; Sato S
J Rheumatol; 2008 Mar; 35(3):451-7. PubMed ID: 18203319
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis.
Chizzolini C; Raschi E; Rezzonico R; Testoni C; Mallone R; Gabrielli A; Facchini A; Del Papa N; Borghi MO; Dayer JM; Meroni PL
Arthritis Rheum; 2002 Jun; 46(6):1602-13. PubMed ID: 12115192
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of anti-topoisomerase I antibody levels determined by ELISA in systemic sclerosis.
Sato S; Hamaguchi Y; Hasegawa M; Takehara K
Rheumatology (Oxford); 2001 Oct; 40(10):1135-40. PubMed ID: 11600743
[TBL] [Abstract][Full Text] [Related]
16. Autoantibody against a protease domain of caspase-8 in patients with systemic sclerosis.
Yamaoka T; Ogawa F; Muroi E; Hara T; Komura K; Iwata Y; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
Clin Exp Rheumatol; 2008; 26(6):998-1004. PubMed ID: 19210862
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of Werner and Bloom syndrome genes in the peripheral blood of HIV-1 infected patients.
Bordi L; Gioia C; Lalle E; Piselli P; Poccia F; Capobianchi MR; Amendola A
Hum Immunol; 2007 Feb; 68(2):91-9. PubMed ID: 17321898
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies against calpastatin in sera from patients with systemic sclerosis.
Sato S; Hasegawa M; Nagaoka T; Takamatsu Y; Yazawa N; Ihn H; Kikuchi K; Takehara K
J Rheumatol; 1998 Nov; 25(11):2135-9. PubMed ID: 9818655
[TBL] [Abstract][Full Text] [Related]
19. Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis.
Kuwatsuka Y; Ogawa F; Iwata Y; Komura K; Muroi E; Hara T; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
Autoimmunity; 2009 Feb; 42(2):120-5. PubMed ID: 19021012
[TBL] [Abstract][Full Text] [Related]
20. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.
Mondini M; Vidali M; De Andrea M; Azzimonti B; Airò P; D'Ambrosio R; Riboldi P; Meroni PL; Albano E; Shoenfeld Y; Gariglio M; Landolfo S
Arthritis Rheum; 2006 Dec; 54(12):3939-44. PubMed ID: 17133607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]